<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8">
 <label>8.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sands</surname>
    <given-names>BE</given-names>
   </name>
   <name>
    <surname>Sandborn</surname>
    <given-names>WJ</given-names>
   </name>
   <name>
    <surname>Panaccione</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>O'Brien</surname>
    <given-names>CD</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Johanns</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Ustekinumab as induction and maintenance therapy for ulcerative colitis</article-title>. 
  <source>N Engl J Med.</source> (
  <year>2019</year>) 
  <volume>381</volume>:
  <fpage>1201</fpage>â€“
  <lpage>14</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1900750</pub-id>
  <?supplied-pmid 31875505?>
  <pub-id pub-id-type="pmid">31553833</pub-id>
 </mixed-citation>
</ref>
